Orlando Health has made a multi-year agreement with Biofourmis, a global technology-enabled care delivery provider, to bring hospital-level care directly to patients’ homes. Orlando Health will leverage Biofourmis’ solution to support its program, which will enable providers across Central Florida to safely and effectively deliver hospital-level care to patients in their homes.
“We have been working closely with Orlando Health to develop a program that we anticipate will become one of the largest and most successful hospital-at-home programs in the U.S. and expand high-quality hospital-level care access across Central Florida,” said Kuldeep Singh Rajput, CEO and founder of Biofourmis. “Our solution is purpose built to scale as rapidly and as large as Orlando Health needs, including our end-to-end technology platform that delivers a comprehensive, continuously updated patient view and actionable care insights, as well as around-the-clock support from our technical, operational and clinical teams.”
Orlando Health’s hospital-at-home program is expected to launch in early 2023. Patient volume is expected to grow steadily as the health system gains experience with the new care delivery approach.
Orlando Health is a 3,238-bed system that includes 23 hospitals and emergency departments, 18 of which are currently operational with five coming soon. More than 4,000 physicians representing more than 100 medical specialties and subspecialties have privileges across the Orlando Health system, which employs more than 25,000 team members and more than 1,200 physicians. In its FY 2022, Orlando Health served more than 142,000 inpatients and 3.9 million outpatients.
Biofourmis’ solution continuously collects vital signs and physiologic signals, and its FDA-cleared Biovitals™ Analytics Engine creates a personalized baseline for each patient that can help clinicians provide the appropriate care. Orlando Health providers can review all data and insights on the continuously updated clinician dashboard and, in a glance, providers can evaluate each patient trajectory. Patients will also have access to their providers through home visits, as well as virtual visits and other communication through a patient app.
“In a short time, we expect hospital-at-home to become a popular care service for patients across the region, which will also ensure adequate access for critically ill and injured patients who require facility-based care,” the Biofourmis CEO added.
Orlando Health selected Biofourmis after a rigorous proposal evaluation process that included four other potential vendors. In addition to the Biofourmis solution’s advanced remote patient monitoring and management and data science capabilities, Orlando Health chose Biofourmis due to the broad array of end-to-end services offered with the platform, including in-home ancillary service ordering and coordination, provider scheduling, patient support, and seamless interoperability with the health system’s Epic electronic health record system.
“Delivering hospital-level care within the patient’s home has been a goal for Orlando Health. This comprehensive solution ensures the safest, highest-quality care as well as ease-of-use for patients and providers,” said Jamal Hakim, MD, Orlando Health Chief Operating Officer. “We are confident that our organization’s dedicated focus on patients, clinical excellence, and operational efficiency—supported by Biofourmis’ solution—will drive the growth of a successful hospital-at-home program.”
Orlando Health, headquartered in Orlando, Florida, is a not-for-profit healthcare organization with $8.1 billion of assets under management that serves the southeastern United States. Orlando Health Cancer Institute has also added CAR T-cell therapy as a new option for treating advanced blood cancers by re-engineering immune cells to fight cancer.
